Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Antihormone |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Exogenous hormones |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
3-beta-androstanediol (substance) |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Peptidhormoner og deres metabolitter og forstadier |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Catecholamine and/or catecholamine derivative |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Prostaglandin |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Prepro-opiomelanocortin |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Melatonin |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Hormone |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Hormones and their metabolites and precursors A - G |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Hormones and their metabolites and precursors H - S |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Hormones and their metabolites and precursors T - Z |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Sex hormone (substance) |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
andet hormon end kønshormon |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Fetoplacental hormone |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Hypofyse- eller binyrehormon |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Antiestrogen |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Antiandrogen |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Antigonadotropin |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
antimineralocorticoid |
Is a |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing bicalutamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing selective estrogen receptor modulator (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing finasteride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing carbimazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Carbimazole 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Carbimazole 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Propylthiouracil 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Finasteride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Clomifene citrate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing cyclofenil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Metyrapone 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Gestrinone 2.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing precisely trilostane 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing precisely trilostane 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Raloxifene hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Raloxifene hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Mifepristone 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing lynestrenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
gestronolhexanoat 100 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Cyproterone acetate 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Cyproterone acetate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
tamoxifen 10 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
tamoxifen 20 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
tamoxifen 10 mg/5 ml sukkerfri oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
tamoxifen 40 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Flutamide 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Bicalutamide 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Bicalutamide 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing androgen receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
kombineret oralt præventionsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
cyproteronacetat + ethinylestradiol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
ethinylestradiol + levonorgestrel flerfase p-pille |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
kønshormonprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing estrogen receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
hormoner, syntetiske substitutionspræparater og antagonister |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
thiourea, antithyroideamiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
thiouracil antithyroideamiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
gestronol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
P-pille, flerfasepræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
fertilitetsfremmende middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
toremifencitrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Cyproterone acetate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
mineralkortikoider og deres antagonister |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
antigonandotropiner, antiøstrogener, antiandrogener |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing nafoxidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
progestinpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing hormone (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing trilostane (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
syntetisk hormonpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing clomifene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
cortisonderivat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
glukokortikoider og syntetiske analoger |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing propylthiouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing iothiouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
antityroidt middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing metyrapone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
naturligt hormon-præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
kontraceptivum til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
clomifencitrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing methylthiouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing androgen receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing tamoxifen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing norgestomet (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing altrenogest (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
syntetisk antihormon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
syntetisk antiandrogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing cyproterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing flutamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
syntetisk antiøstrogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing toremifene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
syntetisk antigonadotropin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing gestrinone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing paroxypropione (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Product containing mifepristone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Endocrine drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Drugs for hypoglycemia |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Diabetic neuropathy treatment [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Corticosteroid replacement therapy |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Steroid disease suppression [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|
Corticosteroid disadvantages [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormoner og deres metabolitter og forstadier |
Inferred relationship |
Some |
|